Real-Time Visualization of HIV-1 GAG Trafficking in Infected Macrophages

Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, USA.
PLoS Pathogens (Impact Factor: 8.06). 04/2008; 4(3):e1000015. DOI: 10.1371/journal.ppat.1000015
Source: PubMed

ABSTRACT HIV-1 particle production is driven by the Gag precursor protein Pr55(Gag). Despite significant progress in defining both the viral and cellular determinants of HIV-1 assembly and release, the trafficking pathway used by Gag to reach its site of assembly in the infected cell remains to be elucidated. The Gag trafficking itinerary in primary monocyte-derived macrophages is especially poorly understood. To define the site of assembly and characterize the Gag trafficking pathway in this physiologically relevant cell type, we have made use of the biarsenical-tetracysteine system. A small tetracysteine tag was introduced near the C-terminus of the matrix domain of Gag. The insertion of the tag at this position did not interfere with Gag trafficking, virus assembly or release, particle infectivity, or the kinetics of virus replication. By using this in vivo detection system to visualize Gag trafficking in living macrophages, Gag was observed to accumulate both at the plasma membrane and in an apparently internal compartment that bears markers characteristic of late endosomes or multivesicular bodies. Significantly, the internal Gag rapidly translocated to the junction between the infected macrophages and uninfected T cells following macrophage/T-cell synapse formation. These data indicate that a population of Gag in infected macrophages remains sequestered internally and is presented to uninfected target cells at a virological synapse.

Download full-text


Available from: David E Ott, Aug 21, 2015
  • Source
    • "In addition, other unknown factors may be required to regulate this targeting (Ono et al., 2004b; Gousset et al., 2008; Mlcochova et al., 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: HIV-1 is an RNA enveloped virus that preferentially infects CD4+ T lymphocytes and also macrophages. In CD4+ T cells, HIV-1 mainly buds from the host cell plasma membrane. The viral Gag polyprotein targets the plasma membrane and is the orchestrator of the HIV assembly as its expression is sufficient to promote the formation of virus-like particles particles carrying a lipidic envelope deriving from the host cell membrane. Certain lipids are enriched in the viral membrane and are thought to play a key role in the assembly process and the envelop composition. A large body of work performed on infected CD4+ T cells has provided important knowledge about the assembly process and the membrane virus lipid composition. While HIV assembly and budding in macrophages is thought to follow the same general Gag-driven mechanism as in T-lymphocytes, the HIV cycle in macrophage exhibits specific features. In these cells, new virions bud from the limiting membrane of seemingly intracellular compartments, where they accumulate while remaining infectious. These structures are now often referred to as Virus Containing Compartments (VCCs). Recent studies suggest that VCCs represent intracellularly sequestered regions of the plasma membrane, but their precise nature remains elusive. The proteomic and lipidomic characterization of virions produced by T cells or macrophages has highlighted the similarity between their composition and that of the plasma membrane of producer cells, as well as their enrichment in acidic lipids, some components of raft lipids and in tetraspanin-enriched microdomains. Great chances are that Gag promotes the coalescence of these components into an assembly platform from which viral budding takes place. How Gag exactly interacts with membrane lipids and what are the mechanisms involved in the interaction between the different membrane nanodomains within the assembly platform remains unclear. Here we review recent literature regarding the role of Gag and lipids
    Frontiers in Microbiology 06/2014; 5:312. DOI:10.3389/fmicb.2014.00312 · 3.94 Impact Factor
  • Source
    • "movement of the viral RNA in the PM and the progressive accumulation of Gag molecules over time, suggest that after the RNA–Gag complex attaches to the PM, it moves in the PM plane to recruit more Gag molecules. Furthermore, it has been shown that HIV-1 Gag translocate from internal compartments towards virological synapses, which are the contact sites that allow the virus to be transferred, between infected macrophages and uninfected T cells (Gousset et al., 2008). Therefore, it is possible that the Gag anchored to the PM can also traffic to these virological synapses. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A critical aspect of viral replication is the assembly of virus particles, which are subsequently released as progeny virus. While a great deal of attention has been focused on better understanding this phase of the viral life cycle, many aspects of the molecular details remain poorly understood. This is certainly true for retroviruses, including that of the human immunodeficiency virus type 1 (HIV-1; a lentivirus) as well as for human T-cell leukemia virus type 1 (HTLV-1; a deltaretrovirus). This review discusses the retroviral Gag protein and its interactions with itself, the plasma membrane and the role of lipids in targeting Gag to virus assembly sites. Recent progress using sophisticated biophysical approaches to investigate - in a comparative manner - retroviral Gag-Gag and Gag-membrane interactions are discussed. Differences among retroviruses in Gag-Gag and Gag-membrane interactions imply dissimilar molecular aspects of the viral assembly pathway, including the interactions of Gag with lipids at the membrane.
    Frontiers in Microbiology 06/2014; 5:302. DOI:10.3389/fmicb.2014.00302 · 3.94 Impact Factor
  • Source
    • "The Jurkat and CEM(12D7) T-cell lines were maintained in RPMI-1640 supplemented with 10% FBS as previously described (Demirov et al., 2002; Freed and Martin, 1994). Human PBMC and primary MDM were prepared and cultured as reported (Demirov et al., 2002; Freed et al., 1995; Gousset et al., 2008). TZM-bl cells (Wei et al., 2002) were obtained from J. Kappes though the NIH AIDS Research and Reference Reagent Program. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Retroviral Gag proteins encode small peptide motifs known as late domains that promote the release of virions from infected cells by interacting directly with host cell factors. Three types of retroviral late domains, with core sequences P(T/S)AP, YPXnL, and PPPY, have been identified. HIV-1 encodes a primary P(T/S)AP-type late domain and an apparently secondary late domain sequence of the YPXnL type. The P(T/S)AP and YPXnL motifs interact with the endosomal sorting factors Tsg101 and Alix, respectively. Although biochemical and structural studies support a direct binding between HIV-1 p6 and Alix, the physiological role of Alix in HIV-1 biology remains undefined. To elucidate the function of the p6–Alix interaction in HIV-1 replication, we introduced a series of mutations in the p6 Alix binding site and evaluated the effects on virus particle production and virus replication in a range of cell types, including physiologically relevant primary T cells and macrophages. We also examined the effects of the Alix binding site mutations on virion morphogenesis and single-cycle virus infectivity. We determined that the p6–Alix interaction plays an important role in HIV-1 replication and observed a particularly severe impact of Alix binding site mutations when they were combined with mutational inactivation of the Tsg101 binding site.
    Virology 09/2009; 391(2-391):284-292. DOI:10.1016/j.virol.2009.06.016 · 3.28 Impact Factor
Show more